Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

President and CFO

See Remarks

Chief Financial Officer

President and CEO

Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors. The company also develops THE-349, a fourth-generation selective epidermal growth factor receptor inhibitor to address C797X-mediated resistance to first- or later-line osimertinib treatment in patients with non-small cell lung cancer. Its development programs address drug resistance mutations in key driver oncogenes, which are mutated genes that cause cancer. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.

Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted thera...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-02-14	Premium	sold	Premium	Premium	Premium	President and CFO
2024-02-14	Premium	sold	Premium	Premium	Premium	-
2024-02-14	Premium	sold	Premium	Premium	Premium	-
2024-02-14	Premium	sold	Premium	Premium	Premium	-
2024-02-14	Premium	sold	Premium	Premium	Premium	-
2023-11-06	Premium	acquired	Premium	Premium	Premium	See Remarks
2023-07-17	Premium	bought	Premium	Premium	Premium	-
2023-07-17	Premium	bought	Premium	Premium	Premium	-
2023-07-17	Premium	bought	Premium	Premium	Premium	-
2022-12-30	Premium	bought	Premium	Premium	Premium	-
2022-12-29	Premium	bought	Premium	Premium	Premium	-
2022-12-29	Premium	bought	Premium	Premium	Premium	-
2022-11-30	Premium	bought	Premium	Premium	Premium	Chief Financial Officer
2022-11-11	Premium	bought	Premium	Premium	Premium	President and CEO
2022-11-07	Premium	bought	Premium	Premium	Premium	-
2022-11-07	Premium	bought	Premium	Premium	Premium	-
2022-01-21	Premium	bought	Premium	Premium	Premium	-
2022-01-21	Premium	bought	Premium	Premium	Premium	-
2022-01-20	Premium	bought	Premium	Premium	Premium	-
2022-01-20	Premium	bought	Premium	Premium	Premium	-
2022-01-19	Premium	bought	Premium	Premium	Premium	-
2022-01-19	Premium	bought	Premium	Premium	Premium	-
2022-01-13	Premium	bought	Premium	Premium	Premium	-
2022-01-13	Premium	bought	Premium	Premium	Premium	-
2022-01-12	Premium	bought	Premium	Premium	Premium	-

THRX - Theseus Pharmaceuticals, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for THRX